Viking Therapeutics Unveils Third Quarter 2025 Financial Results and Update on Clinical Advances Viking Therapeutics reports Q3 2025 financial results, highlighting positive developments in clinical programs for obesity treatment.

Viking Therapeutics Unveils Third Quarter 2025 Financial Results and Update on Clinical Advances #United_States #San_Diego #Viking_Therapeutics #VK2735 #VANQUISH_Trials